Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Questcor Pharmaceuticals Inc (QCOR), Chesapeake Energy Corporation (CHK), And Post-Earnings Bulls

Page 1 of 2

With earnings season in full-swing, and with countless large moving stocks, I am looking at four companies that reported earnings on Wednesday that I believe are a “buy,” regardless of the stock’s initial reaction.

An Under-the-Radar Stock to Watch

Mueller Water Products, Inc. (NYSE:MWA) saw gains of more than 13% after the company announced earnings that handily beat expectations. The company experienced sales growth of 12.6% year-over-year (yoy) and swung from a net loss of $0.70 per share to a profit of $0.05. The company saw a 21.70% boost in the shipment volume of valves, hydrants, and brass products, thus pushing its operating margins higher by 670 basis points.

Here’s the thing, if Mueller Water Products, Inc. (NYSE:MWA) would have seen zero revenue growth with the same margin growth I would have still said it was a “buy.” This company improved drastically, has double-digit growth, and is a very cheap stock with a price/sales ratio of just 0.90. I believe the uptrend for the stock is just warming up, and that further gains are to come as investors take notice of this company.

A Big Miss by the Numbers but a Huge Beat by the Valuation

Questcor Pharmaceuticals Inc (NASDAQ:QCOR) opened on Wednesday with losses of about 3%, but eventually rallied to trade near flat. The company reported earnings that missed expectations by a wide margin. However, the company still saw top-line growth of 41% and when compared to its valuation the stock is very cheap.

Questcor Pharmaceuticals Inc (NASDAQ:QCOR) is trading at just 6 times next year’s earnings, yet has 40% growth. In biotechnology, ratios such as this don’t exist, and when you combine the fact that QCOR pays an annual yield of more than 3% and is buying back its own stock, I am not sure how the stock Is not a buy.

A Controversial Energy Play With Strong Fundamental Improvements

After Chesapeake Energy Corporation (NYSE:CHK) announced its earnings report the stock initially shot higher by 4%, but has since fallen 2% as fears regarding its asset sale and liquidity position resurfaced. While these fears are a reason for concern, I was highly impressed with the company’s quarter, especially considering the volatility of energy at this point in time.

I liked its 9% rise in total production, the lowered guidance on operating expenses, and the fact that Chesapeake Energy Corporation (NYSE:CHK) still has the greatest collection of energy assets in the U.S. So far the company has sold $2 billion of assets with $5 billion left to reach its target. I think the company is improving and with it trading at just 10.0 times next year’s earnings I think CHK is a “Buy” on the post-earnings weakness.

Page 1 of 2